Stocks · News reference
RBC Capital Downgrades Amrize to Underperform, Lowers Price Target to $48
RBC Capital analyst Anthony Codling downgrades Amrize (NYSE:AMRZ) from Sector Perform to Underperform and lowers the price target from $60 to $48.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
This Toast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Wednesday
Wall Street analysts changed outlook on top companies. Check out complete rating changes, including upgrades/downgrades, on our page.
B of A Securities Downgrades Amrize to Underperform, Lowers Price Target to $40
B of A Securities analyst Arnaud Lehmann downgrades Amrize (NYSE:AMRZ) from Neutral to Underperform and lowers the price target from $50 to $40.
8-K filing — Amrize Ltd (AMRZ)
Filed: 2026-09-01 AccNo: 0001140361-26-035332 Size: 136 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers